J. Dai

发表

Comparison of maltose and acarbose as inhibitors of maltase-glucoamylase activity in assaying acid α-glucosidase activity in dried blood spots for the diagnosis of infantile Pompe disease

Yuan-Tsong Chen, D. Millington, D. Bali, 2006, Genetics in Medicine.

Anti-vimentin antibodies: a unique antibody class associated with therapy-resistant lupus nephritis

D. Markovitz, A. Kinloch, M. Townsend, 2020, Lupus.

β2 Agonists enhance the efficacy of simultaneous enzyme replacement therapy in murine Pompe disease.

Songtao Li, D. Bali, D. Koeberl, 2012, Molecular genetics and metabolism.

Enhanced efficacy of enzyme replacement therapy in Pompe disease through mannose-6-phosphate receptor expression in skeletal muscle.

Songtao Li, D. Bali, D. Koeberl, 2011, Molecular genetics and metabolism.

Chronic liver disease and impaired hepatic glycogen metabolism in argininosuccinate lyase deficiency.

J. Marini, L. Burrage, Brendan H. Lee, 2020, JCI insight.

[Effect of intracoronary adenovirus vector encoding hepatocyte growth factor gene on hematopoietic stem cells mobilization in patients with extensive coronary heart disease].

K. Cao, Zhijian Yang, T. Zhu, 2007, Zhonghua xin xue guan bing za zhi.

Predicting cross‐reactive immunological material (CRIM) status in Pompe disease using GAA mutations: Lessons learned from 10 years of clinical laboratory testing experience

C. Rehder, D. Bali, P. Kishnani, 2012, American journal of medical genetics. Part C, Seminars in medical genetics.

A comprehensive testing algorithm for the diagnosis of Fabry disease in males and females.

C. Rehder, M. McDonald, D. Bali, 2020, Molecular genetics and metabolism.

Improved efficacy of gene therapy approaches for Pompe disease using a new, immune-deficient GSD-II mouse model

A. Amalfitano, J. Dai, E. Ding, 2004, Gene Therapy.

Molecular analysis and protein processing in late‐onset pompe disease patients with low levels of acid α‐glucosidase activity

D. Bali, P. Kishnani, J. Goldstein, 2011, Muscle & nerve.

Ningmitai capsules have anti-inflammatory and pain-relieving effects in the chronic prostatitis/chronic pelvic pain syndrome mouse model through systemic immunity

M. Zhang, Chunhua Deng, J. Dai, 2022, Frontiers in Pharmacology.

Clinical laboratory experience of blood CRIM testing in infantile Pompe disease

C. Rehder, D. Bali, P. Kishnani, 2015, Molecular genetics and metabolism reports.

Rapid diagnosis of late-onset Pompe disease by fluorometric assay of alpha-glucosidase activities in dried blood spots.

P. Kishnani, D. Corzo, R. Pomponio, 2007, Molecular genetics and metabolism.

Screening for pompe disease using a rapid dried blood spot method: Experience of a clinical diagnostic laboratory

D. Millington, D. Bali, P. Kishnani, 2009, Muscle & nerve.

Predicting Cross Reactive Immunological Material (CRIM) Status in Pompe Disease Using GAA Mutations: Lessons Learned from 10 Years of Clinical Laboratory Testing Experience

C. Rehder, P. Kishnani, J. Goldstein, 2012 .